Phoenix Life Sciences PLSI Stock
Phoenix Life Sciences Price Chart
Phoenix Life Sciences PLSI Financial and Trading Overview
| Phoenix Life Sciences stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.03 USD |
| Volume | 92 USD |
| Avg. Volume | 40 USD |
| Market Cap | 365.91K USD |
| Beta (5Y Monthly) | -0.922185 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PLSI Valuation Measures
| Enterprise Value | -64739 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.00032258063 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Phoenix Life Sciences Stock Price History
| Beta (5Y Monthly) | -0.922185 |
| 52-Week Change | -99.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
PLSI Share Statistics
| Avg. Volume (3 month) | 40 USD |
| Avg. Daily Volume (10-Days) | 200 USD |
| Shares Outstanding | 10.76M |
| Float | 9.39M |
| Short Ratio | N/A |
| % Held by Insiders | 19.67% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2019 |
| Most Recent Quarter (mrq) | February 28, 2019 |
| Next Fiscal Year End | February 28, 2020 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.79% |
| Return on Equity (ttm) | -71.46% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3117192 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 201.99K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 136.17K USD |
| Total Debt/Equity (mrq) | 1.35 USD |
| Current Ratio (mrq) | 1.759 |
| Book Value Per Share (mrq) | 0.31 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -860030 USD |
| Levered Free Cash Flow (ttm) | -3461889 USD |
Profile of Phoenix Life Sciences
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 4262 Blue Diamond Road |
| ZIP | 89139 |
| Phone | 720 699 7222 |
| Website | https://www.phoenixlife.co |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.
Q&A For Phoenix Life Sciences Stock
What is a current PLSI stock price?
Phoenix Life Sciences PLSI stock price today per share is 0.0001 USD.
How to purchase Phoenix Life Sciences stock?
You can buy PLSI shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phoenix Life Sciences?
The stock symbol or ticker of Phoenix Life Sciences is PLSI.
Which industry does the Phoenix Life Sciences company belong to?
The Phoenix Life Sciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Phoenix Life Sciences have in circulation?
The max supply of Phoenix Life Sciences shares is 3.66B.
What is Phoenix Life Sciences Price to Earnings Ratio (PE Ratio)?
Phoenix Life Sciences PE Ratio is 0.00000000 now.
What was Phoenix Life Sciences earnings per share over the trailing 12 months (TTM)?
Phoenix Life Sciences EPS is 0 USD over the trailing 12 months.
Which sector does the Phoenix Life Sciences company belong to?
The Phoenix Life Sciences sector is Healthcare.